Case File
efta-02582168DOJ Data Set 11OtherEFTA02582168
Date
Unknown
Source
DOJ Data Set 11
Reference
efta-02582168
Pages
3
Persons
0
Integrity
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
From:
Jeffrey Epstein <[email protected]>
Sent:
Tuesday, March 25, 2014 2:27 PM
To:
Tazia Smith
Subject:
Re: *** NEW JOINT BOOKRUN IPO *** TRINET GROUP (NYSE: TNET) ***
ok buy as much as possible
On Tue, Mar 25, 2014 at 8:25 AM, Ta=ia Smith
wrote:
Jeffrey -
Please see below on TriNet (TNET). DB is also a passive bookrunner on King Digital (KING), CBS Outdoor (CBSO),
and Nord Anglia Education (NORD). Will call you to follow up.
Best Regards,
Tazia
*** APPROVED FOR EXTERNAL DISTRIBUTION ***
Issuer: TriNet Group, Inc.
Symbol: TNET
Deal size: 15.0 million shares (100% primary) plus 15% greenshoe (100% secondary)
Offer range: $15.00 —17.00
Exchange: NYSE
Anticipated pricing: Wednesday, March 26th<=sup>
Business description:
TriNet is a leading provider of comprehensive HR solutions for small-to-medium business ("SMBs"). The
Company=enables its clients to outsource their entire HR needs to one partner, allowing them to focus on growing their
core business. TriNet's solution payro=l processing, human capital consulting, employment law compliance and
employe= benefits, including health insurance, retirement plans and workers compensa=ion insurance. TriNet serves
over 8,900 employees and their 231,000 employees in the 47 states, the District of Columbia and Canada and processed
over $17 billion in payroll and insurance premiums for its clients. Regulatory pressures and escalating healthcare costs
are real concerns for many SMBs, and by offering clients a "bundled" solution of outsourcing, Tr=Net helps reduce the
complexity, cost and risk of managing the HR function while helping clients better retain their employees.
EFTA_R1_01759290
EFTA02582168
Roadshow:
Monday March 17th — Midwest
Tuesday March 18th — Mid-Atlantic
Wednesday March 19th — NY Group lunch @ St Regis - 12:30 Fontainbleau room
Thursday March 20th — Boston Group lunch @ Langham Boston — 12:30pm Madison room
Friday March 21st — NY
Monday March 24th — SF
Tuesday March 25th — Denver/LA
Wednesday March 26th KC/Texas & Pricing
Bookrunners:
JPMorgan
Morgan Stanley
Deutsche Bank
Co-managers:
Jefferies
Stifel
William Blair
The issuer has filed a registration statement (including a prospectus) with the SEC for the offering to which this
commun=cation relates. Before you invest, you should read the prospectus in that registra=ion statement and other
documents the issuer has filed with the SEC for more complete information about the issuer and this offering. You may
get these documents for free by visiting EDGAR on the SEC Web site, at www.sec.gov. Alternatively, the issuer, any
underwriter or any dealer participating in the offering will arrange to send you the prospectus if you request it by calling
toll-free 1-800-503-4611 <tel:1-800-503-4611> or by mail from Deutsche Bank Secur=ties Inc., 60 Wall Street, New York,
New York 10016, or by email at [email protected]
2
EFTA_R1_01759291
EFTA02582169
Tazia Smith
Director I Key Client Partners - US
Deutsche Bank Securities Inc
Deutsche Asset & Wealth Management
345 Park Avenue, 26th Floor
New York, NY 10154
This communication may contain confidential and/=r privileged information.
If you are not the intended recipient (or have received this communicationar> in error) please notify the sender
immediately and destroy this
communication. Any unauthorized copying, disclosure or distribution of the<=r> material in this communication
is strictly forbidden.
Deutsche Bank does not render legal or tax advice, and the information
contained in this communication should not be regarded as such.
The information contained in this commun=cation is
confidential, may be attorney-client privileged, may
constitute inside i=formation, and is intended only for
the use of the addressee. It is the=property of
Jeffrey Epstein
Unauthorized use, disclosure or copying=of this
communication or any part thereof is strictly prohibited
and may be unla=ful. If you have received this
communication in error, please notify us=immediately by
return e-mail or by e-mail to [email protected] <mailto:[email protected]> , and
destroy this communication and all copies thereof,
including all attachm=nts. copyright -all rights reserved
3
EFTA_R1_01759292
EFTA02582170
Technical Artifacts (8)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Domain
www.sec.govEmail
[email protected]Email
[email protected]Email
[email protected]Phone
1-800-503-4611Phone
2582168Phone
2582169Phone
2582170Related Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.